Beijing CoSci Med-Tech Co., Ltd. focuses on preclinical, clinical, early phase drug development and industrialization research. The company is at the forefront of the design and development of sustained-release, controlled-release, and orally disintegrating techniques.
Focus Areas
Notable Investments
